FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022648188> ?p ?o ?g. }

• W2022648188 endingPage "541" @default.
• W2022648188 startingPage "535" @default.
• W2022648188 abstract "One-hundred-and-one patients referred because of Raynaud's phenomenon (RP) were prospectively followed for a mean period of 42 months. At presentation they were screened for signs and symptoms of connective tissue disease (CTD) according to a detailed protocol. At presentation 37 patients had primary RP (PRP), nine had RP in combination with vascular occlusive disease (RP-VOD), 25 had one symptom of a CTD (questionable PRP), 13 had two or more symptoms (undifferentiated CTD, UCTD) and 17 had definite CTD. Progression from one of these groups to another was seen in 24 patients and from PRP, RP-VOD or questionable PRP towards a (U)CTD was seen in 19 patients. Patients with one sign of CTD showed a high tendency (56%) to develop CTD. The presence of ANA as detected by immunofluorescence and by immunoblotting at the start of the study was associated with the future development of symptoms of CTD; positive predictive value 65% and 71% and negative predictive value 93% and 83%, respectively. ANA-testing by immunoblotting was of special help in predicting the development of scleroderma, the CREST syndrome and mixed connective tissue disease. In conclusion, testing for ANA by indirect immunofluorescence helps to discriminate between patients with persisting PRP and those who will develop a CTD, while testing for ANA by the immunoblotting technique helps to predict the development of a specific CTD." @default.
• W2022648188 created "2016-06-24" @default.
• W2022648188 creator A5061599622 @default.
• W2022648188 creator A5062638586 @default.
• W2022648188 creator A5072215312 @default.
• W2022648188 creator A5078068722 @default.
• W2022648188 date "1989-12-01" @default.
• W2022648188 modified "2023-10-16" @default.
• W2022648188 title "The diagnostic value of several immunological tests for anti-nuclear antibody in predicting the development of connective tissue disease in patients presenting with Raynaud's phenomenon" @default.
• W2022648188 cites W1494605757 @default.
• W2022648188 cites W1507183450 @default.
• W2022648188 cites W160997634 @default.
• W2022648188 cites W1944505228 @default.
• W2022648188 cites W1976732266 @default.
• W2022648188 cites W1981207374 @default.
• W2022648188 cites W1996642198 @default.
• W2022648188 cites W2015438650 @default.
• W2022648188 cites W2018967405 @default.
• W2022648188 cites W2027063893 @default.
• W2022648188 cites W2028921539 @default.
• W2022648188 cites W2036226275 @default.
• W2022648188 cites W2062680329 @default.
• W2022648188 cites W2064901017 @default.
• W2022648188 cites W2066293475 @default.
• W2022648188 cites W2072346339 @default.
• W2022648188 cites W2073898388 @default.
• W2022648188 cites W2082995756 @default.
• W2022648188 cites W2083033585 @default.
• W2022648188 cites W2083543006 @default.
• W2022648188 cites W2084029202 @default.
• W2022648188 cites W2091039005 @default.
• W2022648188 cites W2103635816 @default.
• W2022648188 cites W2112888006 @default.
• W2022648188 cites W2143611289 @default.
• W2022648188 cites W2146203649 @default.
• W2022648188 cites W2150423878 @default.
• W2022648188 cites W2153709755 @default.
• W2022648188 cites W2157578703 @default.
• W2022648188 cites W2160997099 @default.
• W2022648188 cites W4211097556 @default.
• W2022648188 cites W4238529386 @default.
• W2022648188 cites W4252546942 @default.
• W2022648188 cites W4296464627 @default.
• W2022648188 doi "https://doi.org/10.1111/j.1365-2362.1989.tb00271.x" @default.
• W2022648188 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2515974" @default.
• W2022648188 hasPublicationYear "1989" @default.
• W2022648188 type Work @default.
• W2022648188 sameAs 2022648188 @default.
• W2022648188 citedByCount "51" @default.
• W2022648188 countsByYear W20226481882013 @default.
• W2022648188 countsByYear W20226481882014 @default.
• W2022648188 countsByYear W20226481882015 @default.
• W2022648188 countsByYear W20226481882017 @default.
• W2022648188 countsByYear W20226481882018 @default.
• W2022648188 countsByYear W20226481882021 @default.
• W2022648188 countsByYear W20226481882022 @default.
• W2022648188 crossrefType "journal-article" @default.
• W2022648188 hasAuthorship W2022648188A5061599622 @default.
• W2022648188 hasAuthorship W2022648188A5062638586 @default.
• W2022648188 hasAuthorship W2022648188A5072215312 @default.
• W2022648188 hasAuthorship W2022648188A5078068722 @default.
• W2022648188 hasConcept C111368507 @default.
• W2022648188 hasConcept C125533998 @default.
• W2022648188 hasConcept C126322002 @default.
• W2022648188 hasConcept C127313418 @default.
• W2022648188 hasConcept C142724271 @default.
• W2022648188 hasConcept C159654299 @default.
• W2022648188 hasConcept C180032290 @default.
• W2022648188 hasConcept C198451711 @default.
• W2022648188 hasConcept C203014093 @default.
• W2022648188 hasConcept C2776153627 @default.
• W2022648188 hasConcept C2776670291 @default.
• W2022648188 hasConcept C2778236600 @default.
• W2022648188 hasConcept C2778962941 @default.
• W2022648188 hasConcept C2779075594 @default.
• W2022648188 hasConcept C2779134260 @default.
• W2022648188 hasConcept C2779967694 @default.
• W2022648188 hasConcept C2910997768 @default.
• W2022648188 hasConcept C518705261 @default.
• W2022648188 hasConcept C71924100 @default.
• W2022648188 hasConceptScore W2022648188C111368507 @default.
• W2022648188 hasConceptScore W2022648188C125533998 @default.
• W2022648188 hasConceptScore W2022648188C126322002 @default.
• W2022648188 hasConceptScore W2022648188C127313418 @default.
• W2022648188 hasConceptScore W2022648188C142724271 @default.
• W2022648188 hasConceptScore W2022648188C159654299 @default.
• W2022648188 hasConceptScore W2022648188C180032290 @default.
• W2022648188 hasConceptScore W2022648188C198451711 @default.
• W2022648188 hasConceptScore W2022648188C203014093 @default.
• W2022648188 hasConceptScore W2022648188C2776153627 @default.
• W2022648188 hasConceptScore W2022648188C2776670291 @default.
• W2022648188 hasConceptScore W2022648188C2778236600 @default.
• W2022648188 hasConceptScore W2022648188C2778962941 @default.
• W2022648188 hasConceptScore W2022648188C2779075594 @default.
• W2022648188 hasConceptScore W2022648188C2779134260 @default.
• W2022648188 hasConceptScore W2022648188C2779967694 @default.
• W2022648188 hasConceptScore W2022648188C2910997768 @default.
• W2022648188 hasConceptScore W2022648188C518705261 @default.

• next